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Abstract 
Homocysteic acid (HA) has been established as a pathogen in Alzheimer’s 
disease (AD) in 3xTg-AD model mice. However, it is not established whether 
HA is involved in the AD pathogenesis in humans. We investigated the 
relationship between urinary HA levels and Mini-Mental State Examination 
(MMSE) scores in patients with AD (n = 110, normal =22, AD=88) and found 
a positive, statistically significant relationship between the two variables (r 
= 0.39, p =0.00003, n = 110). This relationship was stronger in females. (r = 
0.47, p = 0.00008, n = 65 in females; r = 0.39, p = 0.02, n =45 in males). 
Urinary HA level difference between normal and AD in female was 
statistical significant (normal:18.4 + 10.6vsAD: 9.1 + 7.2 mM,p<0.01), but 
this difference of male was not statistical significant. (normal:12.7 + 6 vs AD 
8.8 + 7.8).  Smoking, hypertension, and diabetes mellitus decreased urinary 
HA excretion. On the basis of these results, we showed that HA is usually 
excreted into urine in humans and did not affect brain function in normal 
individuals. However, when urinary HA excretion was decreased, HA was 
shown to damage brain function, particularly cognitive ability. To confirm 
our hypothesis, that is, when urinary HA is suppressed to be excreted into 
urine, the blood HA level will be increased, we examined the relationship 
between the urinary HA level and blood HA level in 19 patients. The result 
was shown that the negative statistical significant relationship between 
them was observed (r=-0.6, p=0.007, n=19). From this result, the uremic 
encephalopathy of HA toxicity was confirmed. However it is a question that 
how the blood HA affected the brain cognitive function.  
 The direct effect of green tea leaves ingestion on HA level and MMSE score 
were also observed.  Ingested green tea leaves decreased HA level in blood 
and concomitantly increased MMSE score, suggesting that blood HA could 
affect the cognitive function. But How? Some papers showed the exogenous 
NMDA including HA disrupted blood brain barrier and entered into brain 
and affected the cognitive function to decrease MMSE score. 
   These results indicate that human AD pathogenesis is influenced by HA, 
and that HA is a human pathogen in AD, indicating that the pathogenesis of 
AD is similar to that of uremic encephalopathy.  
Also urinary HA can be used as a biomarker for Alzheimer’s disease. 
 
 3
Introduction  
Amyloid treatment in mice has been shown to be successful in recovering 
memory impairment (1,2). However, many human clinical trials on amyloid 
treatment for Alzheimer’s disease (AD) have failed recently(3). This suggests 
that another pathogenic process must be active in humans. 
We have recently found that homocysteic acid (HA) is an AD pathogen in 
3xTg-AD model mice (with APP, Presenilin and Tau genes) (4). In the 
present study, we investigated whether the pathogenic action of HA is 
observed in humans. The results showed that HA is a human AD pathogen 
as well.  
  
Materials and Methods 
The study protocol was approved by the Juntendo University Hospital Ethics 
Committee, and all patients agreed to the procedure by providing informed 
written consent.  
The patient profiles are shown in Table 1. Urine samples were collected from 
patients in the hospital and the specific gravity of samples was measured. 
Urinary HA level was adjusted to that of 1.020 specific gravity.  
 
Urinary HA level 
High performance liquid chromatography (HPLC) with an ECD detector was 
performed using a previous method with modifications (5). HA (4 mg) was 
added to the urine samples as an internal standard. Urine was diluted 10 
times with water, and 20 μl of diluted urine sample was added to the 
measurement solution, which was composed of 150 μl o-phthaldialdehyde 
reagent and 150 μl mercaptoethanol. Fifteen minutes after mixing the 
diluted urine sample with the measurement solution, the sample was 
injected into the HPLC system. 
 
Blood HA level was measured according to the method of (5). 
 
Green tea leaves ingestion 
16 Alzheimer’s patients (Male5, Female 11) ingested 1 g of green tea leaves 
at every meal for one month. Before ingestion, their MMSE score and HA 
level in blood were measured. After one month, these parameters were 
measured. 
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Results 
Urinary HA levels were significantly higher in normal than that in AD 
patients of female, but male urinary HA levels were not statistical significant 
between normal and patients. (Table 2). 
Urinary HA levels were significantly and positively correlated with 
Mini-Mental State Examination (MMSE) scores (Fig. 1). This correlation 
was stronger in females than in males (Figs. 2 and 3). From Table 2, normal 
female excreted HA more higher than that of male. 
Some smokers as well as patients with diabetes mellitus (DM) and 
hypertension (HT) were included in the study. Figures 4 and 5 clearly show 
that smoking, DM, and HT decreased HA excretion. Fig. 6 shows urinary HA 
of  the mild cognitive impairment (MCI), indicating these urinary HA of 
MCI were around 20 mM. Fig. 7 shows the disease process of AD. I year was 
one year after detecting AD. 2 years indicate 2 years after detecting AD. 
From Fig. 7, it clearly shows that MCI preceeded AD for 1 year and 2 years, 
indicating that disease process was clearly showed by their urinary HA level.  
Table 3 shows the direct effect of green tea leaves ingestion on MMSE score 
and HA level in blood. Clearly shown in Table 3 , green tea leaves decreased 
HA level and concomitantly increased MMSE score, indicating that HA is a 
pathogen in human.  
 Now we are interested in the relationship between the decrease in urinary 
HA level and the increase in blood HA level. Fig. 8 shows the relationship 
between urinary HA level and blood HA level in 19 patients. From Fig. 8,  
the relationship between them was negative statistical significant was 
observed (r=-0.6, p=0.007, n=19). 
From this result, patients showed urinary HA excretion was suppressed and 
their blood HA level increased, which indicated that patients showed an 
uremic encephalopathy of HA toxicity.  
 
Discussion 
Our results clearly indicate that urinary HA levels were positively correlated 
with MMSE scores. That is, when HA was excreted sufficiently into urine, 
cognitive function was normal. However, when HA excretion was decreased, 
cognitive function was impaired, suggesting that HA retained in the body 
caused cognitive impairment. This phenomenon was observed in Table 2. 
That is, Normal cognitive female persons excretes HA statistically 
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significantly higher than female AD patients. And Fig. 8 shows that the 
relationship between urinary and blood HA level is the negative statistical 
significant relation (r=-0.6, p=0.007, n=19), which indicates when the 
urinary HA excretion was suppressed in patients,  the increase in blood HA 
level was observed. Then our hypothesis,  a uremic encephalopathy of HA 
toxicity was confirmed. However it is still question how the blood HA affected 
MMSE score. Now some papers showed that exogenous NMDA including HA 
disrupted Blood Brain Barrier permeability (6,7).  Then the increased level 
of HA in blood can enter into brain by BBB disruption and can suppress the 
cognitive function, which consequently induces the decrease in MMSE score. 
  Some studies have recently reported that the kidneys of patients with AD 
are impaired (8,9), suggesting that the decreased HA excretion due to renal 
failure could be a pathogenic factor in AD.  Also green tea leaves ingestion 
simply but clearly indicated that HA is a pathogen of Alzheimer’s disease in 
human. However we don’t know why green tea leaves decreased HA level. 
But this effect is a real possible phenomenon, because one of authors (HT) 
already observed the green tea prevented Alzheimer’s cognitive decline(10). 
Some powerful component of green tea leaves such as a pyrroloquinoline 
quinine (PQQ) can decrease HA level by inhibiting the HA production, or by 
stimulating HA metabolism. 
 Our recent study (4) showed that HA is the AD pathogen in the 3xTg-AD 
mouse model, but it is unclear whether HA is pathogenic in humans. Our 
observations reported in this study suggest that HA is related to AD 
pathogenesis in humans as well. 
Recent clinical trials on amyloid treatment for AD have all failed. Because all 
AD model mice show a successful recovery from cognitive impairment 
following amyloid treatment, a different pathogenic process for AD must be 
present in humans. We suggest that this process is related to HA considering 
that HA does not induce its toxicity in mice (11). However amyloid treatment 
results in the recovery of cognitive impairment because the brain HA level in 
mice is very low, and it was not toxic (11). But in humans, the brain HA level 
is very high. For example, the urinary HA level in mice is in micromolar 
concentrations (4), whereas that in humans is tens of millimolar 
concentrations, indicating very high levels of HA in the body. These results 
suggest that we should not neglect HA toxicity even after amyloid treatment. 
Our observations also provide other interesting insights that DM and HT 
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decreased the urinary HA level, and these diseases are well-known high risk 
factors for AD (12,13). Furthermore, smoking decreased urinary HA 
excretion, and heavy smoking can result in AD (14). Our results suggest that 
DM, HT, and smoking can induce AD by decreasing urinary HA excretion. It 
is presently unclear how these pathologies suppress HA excretion. However, 
it is known that organic anion transporters in the kidney play an important 
role in the excretion of toxic substances (15). Perhaps DM, HT, and smoking 
affect this transporter system. 
More over, there are many evidences which show the homocysteic acid (HA) 
involvement in human Alzheimer’s pathogenic processes. 
First Vlassenco et al has reported the possible link between regional aerobic 
glycolysis and amyloid deposition in normal brain (16). 
This phenomenon may be induced by HA. First, HA is known as a 
neurotransmitter in normal brain (17). Second, HA induced a seizure of 
immature pup of rat. This brain metabolism was changed to be strong 
glycolysis. (18).  Third, HA is published to be a pathogen of Alzheimer’s 
disease (4) and HA induced amyloid beta42. (5) 
From these evidences, Vlassenco’s report, the possible link between a 
regional glycolysis and amyloid deposition in normal brain, can be induced 
by HA, whose brain will be later Alzheimer’s one, because HA is a pathogen 
of Alzheimer’s disease. 
Second, it has reported that homocysteine-lowering by B vitamins slow the 
rates accelerated  brain atrophy in mild cognitive impairment (19). This 
report shows that homocysteine induced brain atrophy, which induced the 
neurodegeneration.  But we observed that a physiological level of  
homocysteine  did not induce the neurodegeneration (20), then what did 
induce the brain atrophy? 
HA is the possible compound which can induce the brain atrophy. Because 
HA is produced by homocysteine. 
Third, some special food, that is, high fat diet and low carbohydrate diet can 
recover the cognitive impairment of Alzheimer’s patient (21). This special 
food induced the ketone body in human, especially beta-hydroxybutyrate 
(BHB) was induced (21). This BHB is very similar chemical structure as that 
of HA and BHB, then can compete HA toxicity, which induces the cognitive 
impairment (4). 
 In conclusion, our findings indicate that when urinary HA excretion is 
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decreased, HA rises to a toxic level in the body, particularly in the brain. This 
retention of HA induces the AD pathogenic process and cognitive impairment, 
suggesting that the pathogenesis of AD is similar to that of uremic 
encephalopathy.  
Moreover, our findings suggest that urinary HA can be used as a biomarker 
of Alzheimer’s disease.  That is, first normal person’s urinary HA level  
should be observed and if their urinary HA level will be decreased by around 
20 mM , their Alzheimer’s process will be started (Fig. 6). So we should know 
our normal HA level, because our observation indicates that normal HA level 
shows strong individual variation. 
Also our observations indicated that mild cognitive impairment (MCI) 
patients showed their HA levels were around 20 mM, (Fig. 6), indicating that 
urinary HA level at 20 mM is very useful for detecting first Alzheimer’s 
disease process, because disease process of Alzheimer’s disease was started 
around 20 mM of urinary HA (Fig. 7). 
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Figure legends 
 
Fig. 1 Relationship between urinary homocysteic acid (HA) level and 
Mini-Mental State Examination (MMSE) scores. The patients were all 
admitted to the Juntendo University Hospital (n = 110;  females, n = 65, 
males, n = 45; age, 75.8 ± 8 years). 
 
Fig. 2 Relationship between urinary HA levels and MMSE) scores in females 
(n = 65; age, 77 ± 7.8 years). 
 
Fig. 3 Relationship between urinary HA levels and MMSE scores in males  
(n = 45;  age, 74 ± 8.6 years). 
 
Fig. 4 Effect of diabetes mellitus (DM) and hypertension (HT) on urinary HA 
levels and MMSE scores. All patients were female. Green: DM, Red: HT 
 
Fig. 5 Effect of smoking on urinary HA levels and MMSE scores. All patients 
were male. Red: Smokers 
 
Fig. 6 Effect of MCI on urinary HA level and MMSE score. Three MCI 
patients showed their sample by red. 
 
Fig. 7 Disease process from MCI to AD.  1 y indicate one year after AD. 2 y 
indicate two years after AD. Brown square indicates average of MCI, 1 year, 
2 years points. This figures shows the disease process with arrow marks. 
 
Fig. 8 The relationship between urinary HA level and blood HA level. 
19 AD patients submitted their urine and blood. Their urinary HA and blood 
HA were measured. 
 
 
 
 
 
 
 
 12
Table 1 Patient profile 
Number             Age         Body weight 
Total       110             75.8 ± 8 years    53.7 ± 11.4 Kg 
Male        45             74 ± 8.6 years    61.5 ± 7.8 Kg 
Female      65             77 ± 7.8 years    49 ± 10.7 Kg 
 
 
 
Table 2 
       Normal MMSE score (30-29)   Urinary HA level (mM)   p value 
Male           n=9                   12.7 + 6 
Female         n=13                  18.4 + 10.6            
      Alzheimer’s patients
Male          n=36                   8.8 + 7.8                    
Female        n=52                  9.1 + 7.2       p<0.01 vs normal
 
HA, homocysteic acid; MMSE, Mini-Mental State Examination 
 
Table 3   Effect of green tea leaves on MMSE score and HA level in blood   
 
            MMSE score                 HA level in blood  (μM)  
 
Before             14 + 5                          11.6  + 6 
 
                    P<0.05                          p<0.001 
 
After               18 + 4                          1.2 +  1   
                   
                   
Patients agreed with this experiment.  
Male (72.2 + 3.6years, n=5 ) Female (75.4 + 4.7 years, n=11) 
Green tea leaves (1g) were ingested at every meal for one month. Before the 
ingestion of green tea leaves, their MMSE score and HA level in blood were 
measured.  After one month, their MMSE score and HA level in blood were 
measured.  
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Fig. 6 
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